Table 2.
Summary of Pharmacokinetic Parameters After a Single 75 mg Dose of Rimegepant to Healthy Lactating Women (N = 12)
|
Sample medium |
|
---|---|---|
Human milk | Plasma | |
AUC0-lasta | 810.1 (22.4) | NA |
AUC0-infa | 816.1 (22.3) | 4,039.9 (17.4) |
AUCtaua | 798.0 (22.0) | 3,811.9 (17.2) |
Cmax, ng/mL | 169.6 (23.2) | 759.2 (23.0) |
Cav, ng/mL | 34.0 (22.3) | 168.3 (17.4) |
Tmax, hb | 2.0 (1.0, 2.0) | 1.4 (1.2, 1.8) |
Milk:plasma concentration ratio | 0.2 (16.2) |
ng*h/mL.
Median (range).
Data are geometric mean (% coefficient of variation) unless otherwise noted.
AUC, area under the concentration–time curve; NA, not applicable.